Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy

Life Science

S&P 500 Flashes Rare Bullish Signal: After 19% Two-Month Surge, History Says 28% Gain Next

Consumer Goods, Financial Service, Life Science, Technology

Biotech Stocks Surge 61% as CRISPR, Vertex Emerge as Top Picks

Life Science

CVS Health Shows Strong Recovery Momentum, Valuation Remains Attractive

Life Science

Trulieve Becomes First U.S. Cannabis Operator to List on NYSE in Historic Industry Milestone

Cannabis

Intuitive Surgical Draws Big Citadel Bet as Ken Griffin Trims Nvidia, Amazon Stakes

Life Science, Technology

Healthcare Expenditures Continue to Grow, Three Leading Stocks Lead the 2026 Investment Race

Life Science

CVS Health Surges Over 25% Year-to-Date: Why Analysts Keep Lifting Its Price Targets

Life Science

Why Oscar Health Stock Could Keep Climbing After a 90% Rally?

Life Science

Is It Time to Buy This Turnaround Pharma Stock?

Life Science

Parabilis Shatters Biotech IPO Record, Stock Surges 58% in Nasdaq Debut

Life Science

The Stock Price of UnitedHealth Group Still Falls More Than 30% from Two Years Ago, and Policy Dependency Becomes a Key Investment Consideration 

Life Science

RVMD Skyrockets 285% in a Year on Historic Pancreatic Cancer Drug Breakthrough

Life Science

The iShares U.S. Pharmaceutical ETF Has Achieved a Return of Over 42% in the Past Year

Life Science

Breaking Down VKTX: 188% Upside, Pipeline Progress and Key Risks

Life Science